Abstract
Activation of the newly identified σ1 chaperone protein is involved in several aspects of the psychostimulant and addictive effects of cocaine. The development of ligands that selectively target the σ1 protein may lead to putative potent anti-cocaine agents. We report here a new and more convergent synthetic pathway to amino side chain substituted hydantoins. Twenty new analogs of our lead compound were synthesized. None of them showed better in vitro affinity for σ1 receptor than our lead compound. Nevertheless, three of them, obtained as racemates, showed high in vitro affinity and selectivity for σ1 receptor. A preliminary in vivo evaluation of their pharmacological activity identified compound 22 as one that increases cocaine-induced locomotor stimulation and therefore acts as a potential efficient σ1 agonist.
Keywords: 1 protein, agonist, hydantoin, isoquinoline, cocaine, addiction, racemates, protein, hyperlocomotion, stereotypies, Tic-hydantoin, stereochemistry, Glennon's model, HOBt, HBTU, Thin layer chromatography, HPLC, TLC, flash chromatography, Whatman GF/B filters, ad libitum, Dunnett's post-hoc comparison test
Medicinal Chemistry
Title: New Synthesis of Tic-Hydantoins Sigma-1 Ligands and Pharmacological Evaluation on Cocaine-Induced Stimulant Effects
Volume: 6 Issue: 6
Author(s): M. Toussaint, M.-A. Debreu-Fontaine, T. Maurice and P. Melnyk
Affiliation:
Keywords: 1 protein, agonist, hydantoin, isoquinoline, cocaine, addiction, racemates, protein, hyperlocomotion, stereotypies, Tic-hydantoin, stereochemistry, Glennon's model, HOBt, HBTU, Thin layer chromatography, HPLC, TLC, flash chromatography, Whatman GF/B filters, ad libitum, Dunnett's post-hoc comparison test
Abstract: Activation of the newly identified σ1 chaperone protein is involved in several aspects of the psychostimulant and addictive effects of cocaine. The development of ligands that selectively target the σ1 protein may lead to putative potent anti-cocaine agents. We report here a new and more convergent synthetic pathway to amino side chain substituted hydantoins. Twenty new analogs of our lead compound were synthesized. None of them showed better in vitro affinity for σ1 receptor than our lead compound. Nevertheless, three of them, obtained as racemates, showed high in vitro affinity and selectivity for σ1 receptor. A preliminary in vivo evaluation of their pharmacological activity identified compound 22 as one that increases cocaine-induced locomotor stimulation and therefore acts as a potential efficient σ1 agonist.
Export Options
About this article
Cite this article as:
Toussaint M., Debreu-Fontaine M.-A., Maurice T. and Melnyk P., New Synthesis of Tic-Hydantoins Sigma-1 Ligands and Pharmacological Evaluation on Cocaine-Induced Stimulant Effects, Medicinal Chemistry 2010; 6 (6) . https://dx.doi.org/10.2174/157340610793563956
DOI https://dx.doi.org/10.2174/157340610793563956 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design BST-2 Expression in Human Hepatocytes is Inducible by All Three Types of Interferons and Restricts Production of Hepatitis C Virus
Current Molecular Medicine Neuroprotective Effects of Lutein in the Retina
Current Pharmaceutical Design Does Anorexia Nervosa Resemble an Addiction?
Current Drug Abuse Reviews T2 Signal Intensity of the Trigeminal Nerve: A New Diagnostic Criteria for Trigeminal Neuralgia?
Current Medical Imaging Is Formaldehyde the Missing Link in AD Pathology? The Differential Aggregation of Amyloid-Beta with APOE Isoforms In Vitro
Current Alzheimer Research Medical Management of Parkinsons Disease: Focus on Neuroprotection
Current Neuropharmacology Effect of Temperature and pH on the Secondary Structure and Denaturation Process of Jumbo Squid Hepatopancreas Cathepsin D.
Protein & Peptide Letters Cow’s Milk Allergy: Where have we Come from and where are we Going?
Endocrine, Metabolic & Immune Disorders - Drug Targets Natural Products as Potential Anti-Alzheimer Agents
Current Medicinal Chemistry Anti-Inflammatory Activity and Cheminformatics Analysis of New Potent 2-Substituted 1-Methyl-5-Nitroindazolinones
Current Topics in Medicinal Chemistry Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms
Central Nervous System Agents in Medicinal Chemistry Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
Current Neuropharmacology The AICD Interacting Protein DAB1 is Up-Regulated in Alzheimer Frontal Cortex Brain Samples and Causes Deregulation of Proteins Involved in Gene Expression Changes
Current Alzheimer Research Anti-Inflammatory Heat Shock Protein 70 Genes are Positively Associated with Human Survival
Current Pharmaceutical Design Getting in Sync: A New Ready-to-use Biofield Resonance Device (Vita Chip) Reduces Chronic Pain and Increases Wellbeing
Neuroscience and Biomedical Engineering (Discontinued) β-Sheet Breakers for Alzheimers Disease Therapy
Current Drug Targets PON1 Hypermethylation and PON3 Hypomethylation are Associated with Risk of Cerebral Infarction
Current Neurovascular Research Active Coatings: Examples and Applications
Recent Patents on Mechanical Engineering